Article Information
History
- March 4, 2024.
Article Versions
- Version 1 (October 15, 2023 - 23:25).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Qiong He1,*,
- Miao-Miao Zhao1,*,✉,
- Ming-Jia Li1,
- Xiao-Ya Li1,
- Jian-Min Jin2,3,
- Ying-Mei Feng4,
- Li Zhang5,
- Wei-Jin Huang5,
- Fang-Yuan Yang1 and
- Jin-Kui Yang1,✉
- 1Department of Endocrinology, Beijing Diabetes Institute, Beijing Tongren Hospital, Capital Medical University, Beijing, China
- 2Department of Respiratory and Critical Care Medicine, Beijing Tongren Hospital, Capital Medical University, Beijing, China
- 3Department of Internal Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China
- 4Department of Science and Technology, Beijing Youan Hospital, Capital Medical University, Beijing, China
- 5Division of HIV/AIDS and Sex-Transmitted Virus Vaccines, Institute for Biological Product Control, National Institutes for Food and Drug Control (NIFDC), Beijing, China
- ↵✉Correspondence to Jin-Kui Yang (jkyang{at}ccmu.edu.cn) or Miao-Miao Zhao (mmzhao{at}ccmu.edu.cn).
↵* These authors contributed equally.
Posted March 04, 2024.
Hyperglycemia-induced cathepsin L maturation: Linking to diabetic comorbidities and COVID-19 mortality
